KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Amgen (AMGN) Consolidated Net Income (2016 - 2026)

Amgen has reported Consolidated Net Income over the past 18 years, most recently at $1.8 billion for Q1 2026.

  • For Q1 2026, Consolidated Net Income rose 5.14% year-over-year to $1.8 billion; the TTM value through Mar 2026 reached $7.8 billion, up 31.47%, while the annual FY2025 figure was $7.7 billion, 88.53% up from the prior year.
  • Consolidated Net Income for Q1 2026 was $1.8 billion at Amgen, up from $1.3 billion in the prior quarter.
  • Over five years, Consolidated Net Income peaked at $3.2 billion in Q3 2025 and troughed at -$113.0 million in Q1 2024.
  • A 5-year average of $1.6 billion and a median of $1.5 billion in 2022 define the central range for Consolidated Net Income.
  • Biggest five-year swings in Consolidated Net Income: plummeted 103.98% in 2024 and later surged 1630.97% in 2025.
  • Year by year, Consolidated Net Income stood at $1.6 billion in 2022, then plummeted by 52.54% to $767.0 million in 2023, then fell by 18.25% to $627.0 million in 2024, then surged by 112.6% to $1.3 billion in 2025, then skyrocketed by 36.46% to $1.8 billion in 2026.
  • Business Quant data shows Consolidated Net Income for AMGN at $1.8 billion in Q1 2026, $1.3 billion in Q4 2025, and $3.2 billion in Q3 2025.